|§Ú¬O½Ö|§Úªº³Ì·R|¤@¨Ç·Ó¤ù|¦n¤å³¹|¥Í¬¡ª¾°T|°Q½×¯d¨¥ªO|¼g«Hµ¹§Ú|º¶|
°Ñ¦Ò®ø®§¤Q¤»-ºµ¥úÀØ
°Ñ¦Ò®ø®§¤Q¤»-2005-12-21
Mr¦Ñºµªº¸Ü¡G
Á`µ²¤@¦~¦h爲½Ñ¦ì´£¨Ñ¥Íª«Âå¾Ç²°TªºÅªªÌ¤ÏÀ³¡A²`¦Û·Pı¨ì®ÄªG¤£¹ü¡A¥»¤H¨M©w¤µ«á±NºÉ¶q¥H±MÃD¤è¦¡¬°¦U¦ì³ø¾É¬ÛÃö¸ê°T¡A·q«ÝŪªÌ§åµû«ü±Ð¡C
¥»´Á±MÃD¡G¥HÁ{§É¤À¤l¶EÂ_¬°¥D¶b¡A¤Þ¤¶¨äÀ³¥Î¦b¶Ç¬V©Ê¯e¯f¡B´c©Ê¸~½F¡B¦å²G´`Àô¡B°ò¦]ªí²{¤ÀªR»PHTS¤Wªº¦^õX©Ê½×¤å¡A¥H¨Ñ¨ô°Ñ¡C
CCAªºÁ{§É¤À¤l¶EÂ_¯S¥Z
³Ì·s¥Xª©2006¦~²Ä1~2´ÁClin
Chim ActaÂø»x¤Q¤E½g½×¤å¡A¥þ³¡¬O¥Z¸ü¤À¤l¶EÂ_¬ÛÃö±M¤å¡A¯S¦¹´£¥X¤¶²Ð¡C
¥»´ÁCCA¤@¯ëÁ{§É·L¥Íª«¤À¤l¶EÂ_¤å³¹¡A¤¶²Ð¤F¯f¬r°ò¦]«¬§P§O¡B²Óµß¾Ç¡B±H¥ÍÂλP¯uµß¾Ç¶EÂ_¡A¹ï¬ÛÃö¨Ï¥ÎéGª¬±´°w,circularizable
probes¡BµJÁC»Ä¸Ñ§Çªk,pyrosequencing»Pª÷©`¦Ì±´°wµ¥·s§Þ³Nªº¤å³¹¦³¤T½g¡A½sªÌ¥t¥~¥Î¤T½g¤å³¹¤¶²Ð¤F¤À¤l¶EÂ_¦b°ò¦]ªí²{¤ÀªR¡BÃĪ«ªvÀøªºßÓ²z°ò¦]¾Ç,Pharmacogenetics,»P´`Àô¨t²Î¤¤®Ö»Ä¦b¶EÂ_¤WªºÀ³¥Î¡C
Á{§É¤À¤l¶EÂ_¦Û¤½¤¸¨â¤d¦~¤»¤ë¡y¤HÃþ°ò¦]Åépµe¡z§i¤@¬q¸¨¥H¨Ó¡A¦³¤Fµo®i°ò¦¡A¦ý¬O¡A¥u¦³¦b°ª³t©Î¬O°ª³q¶q,high
throughput, HTS¡A¥H¤Î¥i¥H¥Î§C¦¨¥»»P³Ì¤p¼Ð¥»¶q¡A¯à§ä¥X¯e¯f¬ÛÃö¥Ø¼Ð®Ö»Ä§Ç¦CÅܲ§®É¡A¤~·|¦bÁ{§É¤W±o¨ì¹ê¥Î¾÷·|¡C
¦]¦¹¡A¥»´Á¯S¥Z¥H¥|½g¤å³¹¤À§O¸Ôz¤FHTS¸ü¥x¡A¦b¦å²y§Üì°ò¦]«¬Å²©w¡B·L¥Íª«·L°}¦C¡B¦h¤Þ¤l®Ö»ÄÀË©w»P¤@¯ë©Ê¤¶²Ðµ¥À³¥Î©Ê¤å³¹¡C
§Y®É»P©w¶qPCR¤]¦û¤F¥|Ó½g´T¡A¥t¥~¤]¥Î¤F¨â½g½×¤å°w¹ï³æ®Ö苷»Ä¦h«¬©ÊSNP§@¤F½×z¡C
Á`¤§¡A¥»´ÁCCA¤j½d³òªº¥Ñ¤HÃþ»P·L¥Íª«°ò¦]¾Ç¨¤«×¤Á¤J¡A¹ïÁ{§É¤À¤l¶EÂ_¦bÀù¯gºÊ´ú¡BªkÂå¾Ç»P¶Ç¬V©Ê¯e¯f¤WªºÀ³¥Î¡A¾ã²z³Ì·s¸ê®Æ§@¤F¦^õX©Êªº¾ãÅé½×±Ô¡C
Clin
Chim Acta 363 5~228 2006
§Ö³t»P°ª³q¶q®Ö»Ä´ú¸Õ²{ªp»P¥¼¨Ó
µÛªÌ¬O¬O¥»´ÁClin
Chim ActaÁ`½s¿è¡A¥»¤å¥Ñ¤HÃþ°ò¦]Åé»P²É½uÅé°ò¦]Åé³Ì·s¬ã¨s¼Æ¾Ú½Í°_¡A«ÂIÁ`µ²¤F¹L¥h»P¥Ø«eªº¤@¨Ç¤À¤l¶EÂ_¤èªk¡A¨Ò¦p¡F¨Ï¥Î·s»Ã¯À»P¦UºØ»Ã¯À²Õ¦X¨Ó§ï¶i®Ö»ÄÂX¼W®Ä²v¡A¤¶²Ð©Ò¿×¼ö±Ò,hot
start PCR§Þ³N¡Aµ²¦X¼ö±ÒPCR»P·s¤Þ¤l¨Ó°§C«D¯S²§©ÊÂX¼W¤zÂZ¡A¥dÂê®Ö»Ä,locked
nucleic acid»P¥Í肽®Ö»Ä,peptide
nucleic acid§Þ³N¡A°»´ú®Ö»ÄÂX¼Wªº¬V®Æ»P¤Þ¤l¤¶²Ð¡AÂX¼W»P´ú©w¾ã¦X®É¤Þ¤l§Þ³N¡A§Y®ÉPCR»P§Y®É¤ÏÂà¿ýPCR¡A¼Ð»xª«ÂX¼W·s§Þ³N¡A§Y®ÉPCR¤Þ¤l»P±´°w³]p»P¼Æ¾Ú®w¤¶²Ð¡A¯à»PÂX¼W¬Ûµ²¦Xªº§Ö³t»P°ª³q¶q´ú©w§Þ³N¡A·s°T¸¹ÂX¼W§Þ³Nµ¥¡C
³Ì«á¡Aµ§ªÌ¤ÀªR°Q½×¤F®Ö»Ä¶EÂ_¤èªkªº¥¼¨ÓÁͶաF¤@¡B¹ï°»´ú¥¼ÂX¼W®Ö»Ä¡A¬O§_»Ýn§@§ó¦h°T¸¹©ñ¤j¬ã¨s¡H
¤G¡Bµ¥·Å·sÂX¼W¤èªk¬O§_À³¬°ªøµ{°l¨D¥Ø¼Ð¡H
¤T¡B¦p¦ó¼W¥[§Y®ÉPCR»P¶Ç²ÎPCR°ª³q¶q®Ä¯à¡H ¥|¡B°ò¦]ªí²{¤ÀªR¦bÁ{§É¹ê¥Î¤W»ùÈ¡H
¤¡B·L¤p¤Æ¬O§_À³¸Ó¨«¨ì©`¦Ì¯Å¡H
¤»¡BÁ{§É¤À¤l¶EÂ_°l¨Dªº²×·¥¥Ø¼Ð¡H
Ãö©ó³Ì«á¤@ÂI¡Aµ§ªÌ§O±j½Õ¤FÁ{§É¤À¤l¶EÂ_ªº¥¼¨Ó¡F±N·|¥Ñ´ú¸Õ®É¶¡¡B¶gÂà³q¶q¡BÆF±Ó«×¡B·Ç½T©Ê¡B©w¶q¡B²{³õ¨Ï¥Î©Ê»P¦¨¥»µ¥¦]¯À¨Óºî¦X¦Ò¶q¡A¤£µM´N·|¼vÅT¨ì³oÃþ¦yºÝ§Þ³N¦bÁ{§É¤ÆÅç«Ç²Ä¤@½uªº¹ê¥Î©Ê¡C
Csako,
G
CCA
363 6~31 2006
Present
and future of rapid and/or high-throughput methods for nucleic acid testing
¨Ï¥Î©w¶q§Y®ÉPCRºÊ´ú´c©Ê¸~½F³Ì§C´Ý¯d¯fªp
¨Ï¥Î©w¶q§Y®ÉPCR¶i¦æ¶EÂ_¡BÀø®Ä»P³Ì§C´Ý¯d¯fªp,minimal
residual disease, MRDºÊ´ú¡A¤w¸g³vº¥¦¨¬°¹ï¦åÀù¡i¥Õ¦å¯f¡j»P²O¤Ú½F±wªÌ¥²µM¹ê¦æªº¼Ð·Ç°Ê§@¡C
µL½×¬O¯S®í§ÜÅéÀøªk¡B²ÓM§K¬ÌÀøªk©ÎªÌ¬O°ò¦]Àøªk¡A²{¶¥¬q³£¥i¥H±±¨î¦b·¥°ªªºÆF±Ó«×»Pºë·Ç«×¤U¶i¦æ¡C
¦b¤À¤l©w¶q°ò¦¤W¡A¯f±¡°»´ú¡BªvÀø¦¨®Ä»PÀø®ÄÅܤƳ£¥i¥H¦b¯f¼xµo§@»PÀù¯f´_µo¥H«e¶EÂ_¥X¨Ó¡A¹ï´£°ªªv¡²v»Pªø´Á¦s¬¡²v§¡¦³§U¯q¡C
¥»¤å¥Ñ©w¶q§Y®ÉPCR¦b°µDNA-PCR»PRT-PCR®Éªº°»´ú¯S©Ê½Í°_¡AµM«á¡A°Q½×¨ì¹B¥Î¦bMRDºÊ´ú¥Õ¦å¯f»P²O¤Ú½F®Éªº¹ê¨Ò¡F¦pºC©Ê¯áÅè¦åÀù¡B«æ©Ê¦¨Åè²ÓM¦åÀù¡BÂoªw©Ê²O¤Ú½F»P®M²ÓM²O¤Ú½F²ÓM¡A¦b±wªÌ¦å²G»P¯áÅè²G¤¤´c©Ê¸~½F²ÓMªº°ª³q¶qºÊ´ú§Þ³N¡A爲¤F¯à´£°ª¶EÂ_®Ä²v»P¦A²{©Ê¡A¥H¤Î¤¬¬Û¹B¥Î¤£¦P¤ÆÅç»ö¾¹ªº¤ÀªRµ²ªG¡A°ª³q¶q©w¶q§Y®ÉPCR²Ó¸`ªº¼Ð·Ç¤Æ´NÅã±o¯S§O«n¤F¡C
¥»¤åÁöµM°Q½×ªº¬O¡A©w¶q§Y®ÉPCR¹ï¦åÀù»P«DÀN©_ª÷¤ó²O¤Ú½FÀË´ú¤WªºÀ³¥Î¡AŪªÌ¥i¥H·Q¹³¡A¨ä¹ê¡A¹ï¨ä¥L¥ô¦ó²¾ÂतÀù¯gªºªvÀøºÊ´ú¡A²zÀ³¤]¥i¥H¬£±o¤W¥Î³õ¡C
Schuler,
F & Deolken, G
CCA 363 147~56 2006
Detection and monitoring of minimal residual disease by quantitative real-time PCR
¯fì©Ê²Óµß®Ö»ÄªºÁ{§É¤ÆÅç«Ç°»´ú¤èªk
¥»¤å¥Ñ¤@¡B¦UºØ´`Àô¦¡®Ö»ÄÂX¼W¤èªk¤¶²Ð¶}©l¡A¦^ÅU¤FPCR¡B§Y®ÉPCR»PRT-PCR¡Anested
PCR¡APCR-ELISA»P³s±µ酶Ãì¤ÏÀ³LCR¡A¶i¦Ó¤ÀªR¤F¤G¡BùڷŤΨä¥LÂX¼W§Þ³N¨Ò¦p¡G®Ö»Ä§Ç¦C¬°°ò¦ªºÂX¼W¡BÂà¿ý§@¥Î¬É¾ÉÂX¼W¡B¾ãªÑ¨ú¥N¦¡,strand
replacementÂX¼W¡Bºu°é¦¡rolling
circleÂX¼W¡B¤À¤äDNA¥H¤ÎÂø¥æª«¼³®»¦¡ÂX¼Wµ¥§Þ³N¡A¦b¯fì©Ê²Óµß¶EÂ_¤WªºÀ³¥Î¡C
¥»¤å²Ä¤T³¡¤À¤¶²Ð¤F¨Ï¥Î¦h¼Ðªºª«¡A©ÎªÌ³q¥Î¼Ðªºª«¦p16S
RNAªº¯fì©Ê·L¥Íª«°»´ú¤èªk¡F¥]¬A¦h¤Þ¤lPCR¡B·L°}¦C»P¥H§Ç¦C¬°°ò¦ªº¾ß©w¡C
¥|¡B¨Ï¥Î®Ö»ÄÂø¥æ§@¥Î»P½èÃлöªº¯fì©Ê·L¥Íª«°»´ú¤èªk¡F¦p´N¦a¿Ã¥úÂø¥æªk,FISH¡B¥Í肽®Ö»ÄFISH§Þ³N¡B½u§Î±´°w¤ÀªRªk¡BÂø¥æ«OÅ@¤ÀªRªk»P½èÃлöªk¡C
¥»¤å¤]¤ñ¸û¤F¦UºØ®Ö»Ä©â¨ú¦Û°Ê¤Æ»ö¾¹¯S©Ê»P»ù®æ¡AÁקK¥æ¤e¦Ã¬Vªº«~ºÞ¤èªk¡A¥H¤Î°Q½×¦UÓ¤ÆÅç«ÇÀ³¸Ó±Ä¨ú¨º¨Ç·L¥Íª«ªº¤À¤l¶EÂ_¤èªk¡A³Ì«á¡Aµ§ªÌ±N±µªñ¤G¤QºØ°Ó·~¤Æ©Î¬O¥¼°Ó·~¤Æªº·L¥Íª«ÀË©w·s§Þ³N§@¤F½×ÃÒ¡C
¥»¤å¬O¸ê°T¬Û·íÂ×´Iªº¤@½g¦^õX©Ê¤å³¹¡C
Mothershed,
EA & Whitney, AM
CCA
363 206~20 2006
Nucleic
acid-based methods for the detection of bacterial pathogens: Present and
future considerations for the clinical laboratory
¨Ï¥Î®Ö»Ä§Þ³N´ú©wÂo¹L©Ê¯f¬r¸ü¶q»P°ò¦]«¬¤ÀªR
¤À¤l¶EÂ_¤w¸g¦¨¬°¶Ç¬V©Ê¯e¯f°»´ú»PÁ{§ÉºÞ²zªº«n§Q¾¹¡C
¤×¨ä¡A·sªñµo®iªº¦UºØ®Ö»Ä¤À¤l§Þ¥©»P°»´ú§Ç¦C¤èªk¡A¤w¸g¥i¥H§Ö³t¶EÂ_¤Îµû¦ô¯f¬r·P¬Vªº¯f±¡ÅܤơA¦b¯f¬r¾Ç»â°ì¦³¤F²©R©Êªº¬ð¯}¡C
¥»¤å±q¶Ç²ÎPCR¥Xµo¡A±j½Õ§Y®ÉPCR·Ç½T¡B§Ö³t»P©w¶qªº¯S©Ê¡A¹ï¶EÂ_¯f¬r·P¬V¤w¸g¦³¤F·¥¤j°^Äm¡C
µÛªÌ¨Ã¥Ñ¦UºØ°Ó·~¤Æ»P¦U¹êÅç«Ç¦Û¥Î§Y®ÉPCR¸ü¥x§Þ³Nªº¤ÀªR¤¤¡A¤¶²Ð¤F§Y®É®Ö»Ä§Ç¦CÂX¼Wªk,NASBA¡B¤À¤äDNAªk,bDNA¡BÂà¿ý§@¥Î¤¶¾ÉÂX¼Wªk,TMAµ¥¤èªk¡C
¨Ã¥B°Q½×¯f¬r°ò¦]«¬¦b±´°Q§ÜÃÄ©Ê¡BºÊ´ú§Ü¯f¬rªvÀø¤ÏÀ³»P¤Þ¾É¯f±¡ºÞ²z¤Wªº«n°^Äm¡C
¨Ò¦p»¡¡A³æ´N¯f¬r¸ü¶qÅܤƪº´ú©w¡A´N¥i¥H«ü¾ÉÃĪ«ªvÀø¾¯¶q¡A»P¶i¦æÀø®Ä¤ÀªR¡C
°ò¦]«¬¤ÀªR§ó¯à°w¹ï§ÜÃÄ©Ê¥ÎÃÄ¡C
ÁöµM¡Aª½±µ¸Ñ§ÇÂX¼Wªº¯f¬r§Ç¦C¡A¬O³Ì¥i¾a°ò¦]«¬°»´ú¤èªk¡A¦ý¬O¡A»Ýn±M·~¦Ó¥B¶O®É¡C
©Ò¥H¥Î°ò¦]«¬±´°w¤Ï¦VÂø¥æPCR²£ª«»P¨î¤ù¬q¦h«¬©Ê¤ÀªR,RFLP¨âºØ¤èªk¡AÁöµM¦³SNPÅܤƪº§xÂZ¡A¤´µM¦³³\¦h¤H¨Ï¥Î¡A¦h¤Þ¤l»P¦h±´°wPCR¤Î§Y®ÉPCR¿Ä¸Ñ¦±½u¤ÀªR¡A¤]³vº¥¾Ö¦³¥«³õ¡C
¥»¤å³Ì«á¤¶²Ð¤F§Y®ÉPCR¦bC«¬¨xª¢¡BHIV¡BHSV¤ÎHPV¯f¬rÁ{³õ¶EÂ_¤W¡A¤@¨Ç©w¶q»P°ò¦]«¬¤À«¬À³¥Î¡C
Domiati-Saad,
R & Scheuermann, RH
CCA
363 197~205 2006
Nucleic acid testing for viral burden and viral genotyping
´`Àô¨t²Î¤¤®Ö»Ä¤ÀªR¬ÛÃö¶EÂ_§Þ³N¶}µo
°£¤F¶Ç¬V©Ê¯e¯f¥H¥~¡A´`Àô¨t²Î¤¤ÀË´ú¯S®íDNA¡Aì¨Ó¬OºÊ±±¬Y¨ÇÀù¯g²¾Âà»P´_µoªº°»´ú¤â¬q¡A¹ïÃh¥¥°ü¤k¦Ó¨¥¡A¥ÀÅé¦å²M¤¤DNAÀËÅç¡A¹ï¤@¨ÇL¨à¯e¯f»PÃh¥¥¬ÛÃö¨Öµo¯g¶EÂ_¦³¯S§O·N¸q¡C
´`Àô¨t²Î¤¤ªºDNA¤S»P¬Y¨Ç«æ¶E¯e¯f¦p¥~¶Ë»P¤¤·ªºÄY«©Ê¦³ÃöÁp¡C
°£¦¹¥H¥~¡A¹L¥h´X¦~¬ã¨s¤Hû´N¤w¸g¶}©lª`·N¨ì¡A´`Àô¨t²ÎRNA¦bÀù¯g¶EÂ_¤WªºÁ{§É·N¸q¡A¦å¼ß¤¤RNA´ú©w¤w¸g¦¨¬°²£«e¤£¤À©Ê§O»P¦h«¬©ÊªºL¨à¥Í¤Æ¼Ð»xª«¡C
¨ä¥L´`Àô²G¦p§¿²G¤¤ªº®Ö»Ä¹ï¶EÂ_¬Y¨Ç¯e¯f¤]¦³«n·N¸q¡C
¥»¤å«üÂI¥X¤FÁ{§É¤À¤l¶EÂ_¤@Ó«n¶D¨D¤è¦V¡AÁ{§É¤À¤l¶EÂ_©Ò²o¯Aªº¼Ð¥»¥u¦³¨âºØ¡F¯f¨_²Õ´»PÅé´`Àô²G¡A¤Z¬O¯A¤Î¨ì²Õ´²ÓMªº¶EÂ_¡A¥Ñ¨ú¼Ë¡B¼Ð¥»³B²z¡B¼Ð¥»«O¦s»P¾ãÓ«e³B²z³t«×¡A³£¦³¥¦ªº½ÆÂø©Ê¡A¬JµLªkHTS¦Û°Ê¤Æ¥çÃø¥H©w¶qpºâ¡AÅé´`Àô²G¦b¦P¼Ë°ÝÃD¤W¡A§xÃø«×¸û©ö¸Ñ¨M¡C
³o¶µ¼Ð¥»¦]¯À¬OÁ{§É¤À¤l¶EÂ_¯à§_¤W¤ÆÅç«Ç²Ä¤@½uªº«nÃöÁ䤧¤@¡A¤×¨ä¬O¡A¦pªG¯à¦³®Äªº°»´ú¥X¦å²G¤¤Àù²ÓMªì´Á²¾Âà¡A¤µ«á´`Àô¨t²Î®Ö»ÄÀË©w¬ÛÃö§Þ³N¡A¥²µM·|¦³§ó§Ö³tªºµo®i¡C
¥»¤å³Ì«á¤]°Q½×¤F¹ê¥Î¤Wªº¤@¨ÇÃöÁä¦]¯À¡C
Tong,
YK & Lo YMD
CCA
363 187~96 2006
Diagnostic
developments involving cell-free(circulating) nucleic acids
°ò¦]ªí²{¤ÀªR»PÁ{§É¶EÂ_
°ò¦]ªí²{ì¨Ó´N¬O²ÓMªº¤@ºØ爲¤F¥Í¦sµo®i¡A©Ò²£¥Íªº°ÊºA¦æ¬°ÅܤơA¤]´N¬O»¡¡A²ÓM¦b¤£¦Pªº±¡ªp·|¾AÀ³Àô¹Ò¡A¦Ó¦³¤£¦Pªº¤@¸sRNA¤Î³J¥Õ½è³QÂà¸ô»PÂàĶ¥X¨Ó¡A§êºtµÛ¤£¦P¥Í²z¥\¯à¡C
Ä´¦p»¡¡F²ÓM¦b¤£¦P²Õ´¤À¤Æ¶¥¬q¡B³B©ó¤£¦PÀç¾i±¡ªp¡A©ÎªÌ¦³¤º»Ý§ïÅÜ¡]°ò¦]¬ðÅܳy¦¨Àù¯g¡^©Î¬O¥~¨Ó¨ë¿E±¡§Î¡]·L¥Íª«·P¬V¡^¡A§¡ÀH®É·|¦³¤£¦Pªº°ò¦]ªí²{½ü¹ø¡A²×µ²¥X¤£¦Pªº¥Í²z¤ÏÀ³¡C
©ñ±óFL¥Í²z¾Ç»Pµo¨|¥Í²z¾Ç¤£½Í¡A°ò¦]ªí²{¤ÀªR±`¥Î¦b°ò¦¯f²z¾Ç¬ã¨s¤W¡A¨ÓÀˬd¯e¯f¬ÛÃö°ò¦]ÅܤơA§ä¥X¥Í¤Æ¼Ð»xª«©ÎªÌ¬OªvÀøÃĪ«¼Ð¹v¡A¬O°ò¦Á{§ÉÂå¾Ç¬ã¨sªº«n§Q¾¹¡C
Ë©³°ò¦]ªí²{¦b¶EÂ_¤W«n©Ê¦p¦ó¡H¬O¥»¤å°Q½×ªºnÂI¡C
²z·Q¤W¡A°ò¦]ªí²{³Ì¦n¬O¤ÀªR°ò¦]ªí²{ªº³Ì²×¥\¯à©Ê²£ª«-³J¥Õ½è¡A¦ý¬O¡A¤j«¬³J¥Õ½è¤ÀªR´¹¤ù¤´µM¥I¤§Âö¦p¡A¦]¦¹¤j³W¼Ò¥Îªº°T®§RNA¤ÀªR´¹¤ù´N¦¨¬°¤ÀªR°ò¦]ªí²{ªº§Q¾¹¡C
¦bÁ{§É¤WÀ˵ø³æ¤@°ò¦]©Î¤Ö¼Æ°ò¦]ªí²{¤ÀªR®É¡A§Y®É©w¶qRT-PCR,QRT-PCR·|¤ñ·L°}¦C¦³§ó§Ö¡B¼Ð¥»¥Î¶q¤Ö»P¸û¯à°÷·Ç½T©w¶qµ¥ÀuÂI¡A¦Ó¥B¤w¸g±o¨ì¨Ï¥ÎªÌ»{¥i¡C
¦ý¬O¡A·L°}¦C¦n³B¬O¦b³æ¤@¹êÅ礤¡A¥i¥H±o¨ì¤j¶q¦h°ò¦]ªí²{ªº°T®§¡A¦Ó¥B¤£»Ýn¹ï¼Ð¥»»P°ò¦]¦³¥ô¦óI´º¸ê°T¡A¦]¬°¡A¨Ï¥Î¼Ð¥»¶q¸û¦h¡A¤º¸ÕÃè»P¤p¤Õ°w¨ú¼Ëªº¼Ð¥»¡A¦b·L°}¦C¼Æ¨Ã¤£¾A¥Î¡C
¦b¦h°ò¦]ªí²{¤ÀªR¤W¡AÁ{§É¨Ï¥Î»ùÈ¥²¶·¶}µo¥X¨¬°÷¸gÀٮįq²£«~¡A»P¸g¹LÄY±KªºÁ{§Éµû¦ô¡A¤~¯à¦bÅé¥~Á{§É¶EÂ_¥«³õ¤W¤j©ñ¥ú¨~¡C
Sandvik,
et al
CCA
363 157~64 2006
Gene expression analysis and clinical diagnosis